A 60-year-old male presented to the emergency department with the worst headache of his life along with nausea and vomiting. Subarachnoid hemorrhage (SAH) occurs when blood enters the subarachnoid space surrounding the brain. The most common cause is a ruptured brain aneurysm. Initial management included a CT scan, which has high sensitivity in detecting SAH, control of blood pressure to reduce risk of rebleeding, administration of nimodipine to prevent vasospasm, and neurosurgical consultation. The patient was admitted to the ICU for monitoring and treatment of potential complications of SAH such as rebleeding, vasospasm, hydrocephalus, and seizures.
Subarachnoid hemorrhage a major complication ,this presentation can help you understand the disease, the signs & symptoms and give you the diagnostic feature ,I hope you well enjoy studying it ... Good luck :)
Subarachnoid hemorrhage a major complication ,this presentation can help you understand the disease, the signs & symptoms and give you the diagnostic feature ,I hope you well enjoy studying it ... Good luck :)
Acute stroke management
IV thrombolysis guidelines
IV thrombolysis side effects
Early CT changes in stroke
ASPECTS scoring
AHA stroke guidelines
Thrombolysis controversies
Intracerebral hemorhage Diagnosis and managementRamesh Babu
About ICH - Diagnosis and management, Discussed the clinical presentation, evaluation, radiological features and management including recent guidelines
Acute stroke management
IV thrombolysis guidelines
IV thrombolysis side effects
Early CT changes in stroke
ASPECTS scoring
AHA stroke guidelines
Thrombolysis controversies
Intracerebral hemorhage Diagnosis and managementRamesh Babu
About ICH - Diagnosis and management, Discussed the clinical presentation, evaluation, radiological features and management including recent guidelines
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
2. Background
Etiology of SAH
Risk factors of SAH
Diagnostic investigations
Management of SAH in ED
Disposition
Complication of SAH
3. A 60 year old male k/c/o HTN presented to the
emergency department complaining of a sudden,
acute onset headache “worst headache of my life “ that
radiated into his neck. Symptoms began three hours
prior to presentation and were associated with nausea
and vomiting.
10. Incidence about 9-10/100,000/yr
Higher in Japan (3 times) and Finland
Mean age of onset 51 years (6th decade)
Facts and figures
Men predominate until age 40, then more
women (55%); some studies – 3:2 ratio
30 % rupture during sleep??
About 50 % of patients with an aneurysm have
warning prior to SAH (6-20 days).
11. Average case fatality rate for SAH was 51 %
Population-based study in England with essentially
complete case ascertainment
24 hour mortality: 25%
7 days: 37%
30 days: 45%
Pobereskin JNNP 2001;70:340-3
12. Hypertension
Cigarette smoking
Oral contraceptives
Alcohol consumption
Diurnal variations in blood pressure
Pregnancy and parturition
Slight increased risk with advancing age
Following cocaine abuse
13. Headache:
Features: Sudden and severe "worst headache of my life“
Associated Symptoms:
brief loss of consciousness (coma is unusual) 57%
nausea or vomiting 77%
meningismus 35%??
Seizure <10% poor prognostic indicator
14. CT Scan :
Within 6-12 hr sensitivity 100% (Perry JJ ,et al, 2011)
CT sensitivity progressively declines over time to about 58% at day five.
Lumbar Puncture:
LP is mandatory if strong suspicion of SAH despite negative CT
Negative CT and LP effectively eliminate the diagnosis of SAH
Follow-up LP unnecessary , If CT scan preformed within 6 hr.
Findings: elevated opening pressure and an elevated RBC count in all
tubes, Xanthochromia
15.
16. MRI:
Less sensitive than CT scan in diagnosing acute SAH
FLAIR and T2 have a high sensitivity in patients with a
sub-acute presentation of SAH
17.
18. If there is a large amount
of SAH particularly in the
basal cisterns, sulci &
fissures the physician
should consider a
ruptured aneurysm
19. Traumatic SAH occurs most
commonly over the cerebral
convexities or adjacent to
otherwise injured brain (i.e.
adjacent to a cerebral
contusion)
20. Angiography:
To determine the etiology of hemorrhage
DSA
MRA /CTA
CTA/MRA
Conventional
angiography
•noninvasive tests
•screening and pre-surgical
planning
•identify aneurysms 3 to 5
mm or larger
•Less resolution than
conventional Angiography
•Less sensitive
-Better resolution
-High sensitivity in detecting
aneurysm
-invasive
21. GRADE SIGNS/SYMPTOMS SURVIVAL
1 Asymptomatic/Minimal headache or
neck stiffness
70%
2 Severe headache, stiff neck, no
neurologic deficit except cranial
nerve palsy
60%
3 Drowsy/ minimal neurological deficit 50%
4 Stuporous with hemeparesis 20%
5 Comatose with decereberate
posturing/response
10%
HUNT AND HESS IN 1968
23. GRADE CT APPEARANCE
1 No blood detected
2 Diffuse deposition or thin layer with all vertical layers (in
interhemispheric fissure, insular cistern, ambient cistern)
less than 1 mm thick
3 Localized clot and/or vertical layers 1 mm or more in
thickness
4 Intracerebral or intraventricular clot with diffuse or no
subarachnoid blood
FISHERS
CLAASSENS MODIFICATION
GRADE CT APPEARANCE
0 No SAH or IVH
1 Minimal SAH and no IVH
2 Minimal SAH with bilateral IVH
3 Thick SAH (completely filling one or more cistern or fissure)
without bilateral IVH
4 Thick SAH (completely filling one or more cistern or fissure)
with bilateral IVH
24. ABC
Triage and transport patients with ALC or an abnormal
neurologic examination to the closest medical center
with a CT scan and neurosurgical backup.
25. ABC
Intubation.
Acute medical care:
Control BP (decrease risk of Rebleeding):
sBP<160 or mean arterial BP <110
Use Labetalol, nicardipine
DVT prophylaxis :
pneumatic compression stockings.
unfractionated heparin 5000 units TID can be added.
IV fluid
analgesia
kept at bed rest
26. Nimodipine {CCB} (60mg PO or NGT every 6hr)
reduce incidence and severity of Vasospasm.
Antifibrinolytic agents (eg, tranexamic acid)
Reduce risk of re-bleeding
Antiepileptic drug therapy and steroids:
controversial
Statins: unknown mechanism but advisable
27. ICU bed
Neurosurgeon & neuroradiologist consultation:
for surgical clipping or endovascular coiling
Nonaneurysmal SAH generally has a more benign
course, so angiographic intervention is not typically
undertaken in these cases.
28. Re-bleeding:
8 to 23 %
highest in the first 24 hours
Manifestation : acute deterioration of neurologic status
accompanied by appearance of new hemorrhage on CT scan
Aneurismal Rx is best way to prevent re-bleeding.
Vasospasm and Delayed cerebral Ischemia:
40 to 60 %
Late presentation: >3 days
Manifestation: neurologic deterioration in LOCor new focal
neurologic deficits
29. Hydrocephalus:
15% of pt with SAH
75% of pt resolve spontaneously
Seizure
Hyponatremia
Cardiac abnormalities:
ECG changes:
ST segment depression, QT interval prolongation, deep symmetric
T wave inversions, and prominent U waves
Left ventricular dysfunction
Elevated trop I level
Elevated BNP
-the dura mater is attached to the skull, or to the bones of the vertebral canal in the spinal cord
-arachnoid is attached to the dura mater
-pia mater is attached to the central nervous system tissue
-Most SAHs are caused by ruptured saccular aneurysms>> event with mortality rates that approach 50 percent,
perimesencephalic hemorrhage
-Mortality rates due to SAH appear to be decreasing over time in Western populations [1-4]. Improvements in rates of smoking, treatment of hypertension, and management of SAH are plausible but unproven reasons for the reduction in mortality. Improved diagnostic accuracy over time, including exclusion of SAH mimics, as well as therapeutic advances may also be playing a role
-perimesencephalic hemorrhage, in which the blood is limited to the subarachnoid spaces around the midbrain (i.e. mesencephalon). In these, the origin of the blood is uncertain
-Cocaine-related SAH occurs in younger patients and has an outcome similar to that in other SAH patients.44 Diabetes does not appear to be a risk factor for SAH.
-
-Meningismus and often lower back pain may not develop until several hours after the bleed since it is caused by the breakdown of blood products within the CSF, which lead to an aseptic meningitis.
-The sensitivity of head CT for detecting SAH is highest in the first 6 to 12 hours after SAH (nearly 100 percent) and then progressively declines over time to about 58 percent at day five
-Some studies and experts suggest that the sensitivity of CT when performed within six hours of the onset of symptoms is sufficiently sensitive (100 percent) to make a follow up LP unnecessary
*comment on follow up with LP:
here are important caveats that suggest that this approach may not be generally applicable. One is that such studies are performed in centers where CT scans are generally interpreted by expert reviewers. Another is that the sensitivity of CT may be reduced, when symptoms are atypical, such as isolated neck pain. The sensitivity of head CT is also reduced with more minor bleeds; in one study, for example, a minor SAH was not diagnosed by CT scan in 55 percent of patients; lumbar puncture was positive in all cases
============================
Xanthochromia :
-represents hemoglobin degradation products.
-unexplained xanthochromic supernatant in CSF is highly suggestive of SAH.
-The presence of xanthochromia indicates that blood has been in the CSF for at least two hours; therefore if the CSF is analyzed quickly after a traumatic LP, there will not be xanthochromia.
-Xanthochromia can last for two weeks or more
However, if LP is performed within two hours after the onset of SAH, xanthochromia may similarly be absent; the absence of xanthochromia cannot be used as evidence of a traumatic tap if an LP is performed in a SAH of less than two hours duration. For a LP performed several hours after the ictus, a finding of erythrocytosis without xanthochromia is unlikely to be SAH [38]. [39,40].
-CT scan :cornerstone of SAH diagnosis is the noncontrast head CT scan
-The sensitivity of head CT for detecting SAH is highest in the first 6 to 12 hours after SAH (nearly 100 percent) and then progressively declines over time to about 58 percent at day five
The grading system proposed by Hunt and Hess (table 1) and that of the World Federation of Neurological Surgeons (WFNS) (table 3) are among the most widely used
The WFNS system incorporates the Glasgow Coma scale (table 4) combined with the presence of motor deficit.
-The Fisher grade is an index of vasospasm risk based upon a CT-defined hemorrhage pattern
- Claassen grading system is a similar index of the risk of delayed cerebral ischemia due to vasospasm
-ensure and maintain an adequate ABC
Intubate to:
To protects them from aspiration
to hyperventilate patients with signs of herniation.
ndications for endotracheal intubation include a GCS ≤8 (table 1), elevated ICP, poor oxygenation or hypoventilation, hemodynamic instability and requirement for heavy sedation or paralysis.
Thiopental and etomidate are the optimal induction agents in subarachnoid hemorrhage (SAH) during an intubation
ETOMIDATE used for induction in hypertensive or normotensive pt
Thiopental use in HTN pt only: because of its propensity to drop systolic blood pressure (SBP), which is the leading cause of secondary brain injury
Precautions:
Avoid excessive Hyperventilation target PaCO2 30-35 Excessive hyperventilation may be harmful to areas of vasospasm.
Avoid excessive sedation: increase ICP and makes serial neurologic exams more difficult
In case of increase ICP:
– raise head of stretcher 20o if patient hemodynamically stable
– intubate and hyperventilate (100% O2) to a pCO2 of 30-35 mmHg
mannitol, which reduces ICP 50% in 30 minutes, peaks after 90 minutes, and lasts 4 hours
furosemide, also decrease ICP without increasing serum osmolality
ntravenous steroid therapy to control brain edema is controversial and debated
-the 2012 American Stroke Association guidelines state that when definitive treatment of the aneurysm is unavoidably delayed and there are no other contraindications to treatment, short term therapy (<72 hours) with tranexamic acid or aminocaproic acid is reasonable [7].
-Many experts believe that seizure prophylaxis in the setting of an unsecured aneurysm is reasonable, given the relatively low risk associated with AED administration versus the potential deleterious effects of seizures on an already dysautoregulated brain [4,46]. However, evidence from a large case series suggests that AED exposure to phenytoin may be associated with worse neurologic and cognitive outcome after SAH [47]. Therefore, the use of AEDs for seizure prophylaxis after SAH should probably be minimized whenever possible; and phenytoin is generally avoided.
-Guidelines from the American Stroke Society and other expert opinion state that despite lack of conclusive evidence of benefit, it is reasonable to administer statin therapy to patients after SAH to prevent vasospasm
-Clipping requires a craniotomy (opening of the skull) to locate the aneurysm, followed by the placement of clips around the neck of the aneurysm.
Coiling is performed through the large blood vessels (endovascularly): a catheter is inserted into the femoral artery in the groin and advanced through the aorta to the arteries (both carotid arteries and both vertebral arteries) that supply the brain
Cerebral perfusion pressure (CPP) equals the mean arterial pressure (MAP) minus the ICP.
Intravenous fluid administration should target euvolemia and normal electrolyte balanc
Vasospasm:
Vasospasm causes symptomatic ischemia and infarction in approximately 20 to 30 percent of patients with aneurysmal SAH
severity of symptoms depends upon the artery affected and the degree of collateral circulation
Fisher (table 5) and Claassen (table 6) are often used to predict the likelihood of vasospasm and cerebral ischemia.
Other factors:
Hyperglycemia
Age <51
High grad of severity
Hydrocephalus:
Hydrocephalus after SAH is thought to be caused by obstruction of cerebrospinal fluid (CSF) flow by blood products or adhesions, or by a reduction of CSF absorption at the arachnoid granulations
-hyponatremia is due to increased secretion of antidiuretic hormone, which may result from either the syndrome of inappropriate ADH secretion
-Myocardial injury is most likely the result of a centrally mediated release of catecholamines within the myocardium due to hypoperfusion of the posterior hypothalamus.